<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002863'>Myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) are a <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> group of clonal stem cell disorders that are characterized by <z:mp ids='MP_0000002'>morphology</z:mp> identifying dysplastic changes in one or more cell lineages, peripheral blood cytopenias and a propensity to evolve into secondary <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>CD34 is commonly expressed in <z:hpo ids='HP_0000001'>all</z:hpo> types of childhood <z:hpo ids='HP_0001909'>leukemias</z:hpo>, whereas CD117 is a reliable and specific marker to detect <z:hpo ids='HP_0001909'>leukemia</z:hpo> cells committed to myeloid lineage </plain></SENT>
<SENT sid="2" pm="."><plain>Co-expression of CD34/CD117 may strongly suggest the diagnosis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> (Rytting ME </plain></SENT>
<SENT sid="3" pm="."><plain>Pediatric <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Curr hematol Rep 2004;3(3):173-7 </plain></SENT>
<SENT sid="5" pm="."><plain>May; Uçkan D, Hiçsönmez G, Yetgin S, Gürgey A, Cetin M, Karaağaoğlu E, et al </plain></SENT>
<SENT sid="6" pm="."><plain>CD34/CD117 co-expression in childhood <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0001909'>Leukemia</z:hpo> Res 2000;24:201-6.) </plain></SENT>
<SENT sid="8" pm="."><plain>We describe the case of a 22 month-old-girl with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and <z:e sem="disease" ids="C0013080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Down syndrome</z:e> who was presented with severe <z:hpo ids='HP_0001903'>anemia</z:hpo> and <z:hpo ids='HP_0001894'>thrombocytosis</z:hpo> at diagnosis, transformed into <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>-M7 </plain></SENT>
<SENT sid="9" pm="."><plain>In our patient, CD34 and CD117 markers were positive on the blast cells of the BM 6 months before the chemotherapy decision </plain></SENT>
<SENT sid="10" pm="."><plain>As the disease progressed, CD34/117 co-existence was increased and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> transformed into <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>As a result, an increase in CD34 and CD117 positivity of the BM blast cells may be associated with a higher risk of leukemic transformation </plain></SENT>
</text></document>